Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05296239 · ClinicalTrials.gov registry record · NA

SimpleC Wellness Platform With Social Robot Interaction

A NA study of Aging and Mild Cognitive Impairment, sponsored by SimpleC.

Completed
Registry status
NA
Development phase
26
Enrollment target
2
Study locations

NCT05296239 is a NA study of Aging and Mild Cognitive Impairment that has completed, run by SimpleC. The registered enrollment target is 26 participants, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05296239, a NA study of Aging and Mild Cognitive Impairment, has completed, sponsored by SimpleC.

COMPLETED
Registry status
NA
Development phase
26 participants
Enrollment target
2
Study locations

Study Summary

This implementation study will be conducted to test a Socially-Assistive Robot (SAR) system for residents in an Assisted Living environment. The goal of the SAR system is to enhance social engagement and connectedness. The system engages residents via robot-facilitated activities such as trivia and reminder and is integrated with the SimpleC Wellness Platform.

Interventions

  • OTHER SimpleC Wellness Platform with Social Robot Interaction

Study Locations (2)

Georgia

  • University of Georgia - Athens
  • SimpleC, LLC - Atlanta

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2022-02-03
Est. Completion 2022-03-07
Phase NA

Sponsor

SimpleC

2 total trials

What the Registry Record Tells You About NCT05296239

The ClinicalTrials.gov registry entry for NCT05296239 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower). The listed sponsor is SimpleC, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Aging appearing as the primary indexed condition, and to 1 intervention - of which SimpleC Wellness Platform with Social Robot Interaction is the first listed.

NCT05296239 reports 2 study locations spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT05296239 about?

NCT05296239 is a clinical study titled "SimpleC Wellness Platform With Social Robot Interaction". This implementation study will be conducted to test a Socially-Assistive Robot (SAR) system for residents in an Assisted Living environment. The goal of the SAR system is to enhance social engagement and connectedness. The system engages residents via robot-facilitated activities such as trivia and ...

What is the current status of trial NCT05296239?

This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2022-02-03. Estimated completion is 2022-03-07.

What conditions does trial NCT05296239 study?

This clinical trial studies the following conditions: Aging, Mild Cognitive Impairment, Dementia, Quality of Life, Cognitive Impairment.

What interventions are being tested in trial NCT05296239?

The interventions under investigation include: SimpleC Wellness Platform with Social Robot Interaction (OTHER).

Who is sponsoring clinical trial NCT05296239?

This trial is sponsored by SimpleC, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05296239 being conducted?

This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.